Current Edition

Upcoming Events

Advertisement

news

Pfizer stocks cancer drug pipeline with $2.3B deal for Trillium

Pfizer is building up its pipeline of experimental cancer medicines, announcing Monday a deal to buy the Cambridge, Massachusetts-based biotech Trillium Therapeutics ...
Continue Reading →